As of Jun 23
| 0.00 / 0.00%|
The 23 analysts offering 12-month price forecasts for CSPC Pharmaceutical Group Ltd have a median target of 53.47, with a high estimate of 61.26 and a low estimate of 48.88. The median estimate represents a +22.98% increase from the last price of 43.48.
The current consensus among 23 polled investment analysts is to Buy stock in CSPC Pharmaceutical Group Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.